Frontlight ResearchEarly access
Trial site
Zhoushan hospital
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Triple-negative breast cancer2 trials
- Bronchiectasis1 trial
- Chronic kidney disease1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 42 trials
- Phase 21 trial
- Phase 2/31 trial
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Not yet recruiting3 trials
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Guangdong Provincial People's Hospital1 trial
- RenJi Hospital1 trial
- Second Affiliated Hospital, Zhejiang University, School of Medicine1 trial
- Shanghai Jiao Tong University School of Medicine1 trial
- and 1 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bronchiectasis1 recruiting
- COPD1 recruiting
- Coronary artery disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026